calendar

3 catalysts · 7 patent expiry · 7 phase 2 completion · 5 phase 1 completion · 4 phase 1 initiation · 3 constraining patent expiry europe · 3 drug expiry

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

show past →

sort

soonest latest type sponsor alpha

type: adcom×type: drug expiry×TA: infectious-disease×clear all

type

patent expiry7
phase 2 completion7
phase 1 completion5
phase 1 initiation4
constraining patent expiry europe3
drug expiry3

phase 2 initiation3

phase 3 completion3

phase iv trial initiation1

phase 1 2 completion1

therapy area

Infectious Disease3

Week of Apr 27, 2026

›Apr 28, 2026drug expiry88d agoGSK plc — cabotegravir sodium (Drug Expiry (US))cabotegravir sodium

Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

full page →cabotegravir sodium →source: globaldata

›Apr 28, 2026drug expiry88d agoViiV Healthcare UK Ltd — cabotegravir LA (Drug Expiry (US))cabotegravir LA

Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

full page →cabotegravir LA →source: globaldata

›Apr 28, 2026drug expiry88d agoViiV Healthcare UK Ltd — cabotegravir + rilpivirine LA (Drug Expiry (US))cabotegravir + rilpivirine LA

Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

full page →cabotegravir + rilpivirine LA →source: globaldata

$GSK51.35+1.20%